Viking Therapeutics (VKTX) stock price forecast: what to expect?

2:35 pm ET, 31 May 2018

Viking Therapeutics (VKTX) stock shot up over 100%, despite the fact that ValueEngine downgraded the company from  Strong Buy to Buy.

The stock moved up in response to Madrigal Pharmaceuticals' announcement of successful 36-week results from a Phase 2 study of NonAlcoholic SteatoHepatitis (NASH) candidate MGL-3196, a thyroid hormone receptor-beta agonist.  Viking's NASH candidate, Phase 2-stage VK2809, has the same mechanism of action. 

What can you expect now--and what's the VKTX stock price forecast?  

We looked at the technical analysis for Viking.  The short-term sentiment is weak, while mid- and long-term the stock looks strong.  

Based on Finstead research, VKTX stock upside is negative (you can also search for 'VKTX upside' on Finstead.com to get the latest results).

Over the last year, VKTX returned +623.47%.  This return is higher than Biotechnology sector (47.47%), Healthcare industry (38.13%), S&P 500 (12.95%)  returns.

Viking Therapeutics is a clinical-stage biopharmaceutical company, focused on the development of therapies for metabolic and endocrine disorders. Its lead clinical program is VK5211, which is in phase II clinical trials for acute rehabilitation following hip fracture surgery. 

The company also develops VK2809 for the treatment of hypercholesterolemia and fatty liver disease, which is looking quite promising, based on today's news.

Disclaimer: The news article above expresses the author’s opinion about the topic of the article. We strongly advise you not to base your investment decisions just on this article alone. If you’d like to become a writer for Finny Bites, please send us an email at hi@askfinny.com.

Viking Therapeutics, Inc. (VKTX) Stock Guide

Updated at: 7:38 pm ET, 12 Jul 2020

Before we start: if you're looking for VKTX stock price, you can quickly find it out by visiting Finny and typing "VKTX quote". If you're looking for a quick scoop on VKTX stock (chart, price target, market cap, news and buy or sell analysis), go to Finny and look for "VKTX". You'll get all this info in one place. Or you can just type "VKTX news" to get the latest stock news.

Looking to buy or sell Viking Therapeutics, Inc. (VKTX)? Interested in getting the full scoop on VKTX, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place.

In this VKTX stock guide, we'll address key questions about VKTX, above and beyond what you can find on Yahoo Finance, Zacks, MarketWatch or Morningstar.

Here is what you'll be able to find in this guide:

Earnings and Dividends: earnings, earnings date, dividend rate and dividend yield;
Analyst Predictions: stock forecast and analyst ratings;
Analysis: Finny Score and buy or sell analysis;
Key Stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio, industry, sector, and number of employees.

And here is the list of questions we'll answer:
1. What are VKTX earnings?
2. When is VKTX earnings date?
3. What is VKTX stock forecast (i.e., prediction)?
4. VKTX buy or sell? What is VKTX Finny Score?
5. What are the reasons to buy VKTX? Why should I buy VKTX stock?
6. What are the reasons to sell VKTX? Why should I sell VKTX stock?
7. What are VKTX key stats: revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

So let's start. Scroll down to the question that interests you the most.

Earnings and Dividends

1. What are VKTX earnings?

VKTX trailing 12-month earnings per share (EPS) is -$0.42.

2. When is VKTX earnings date?

VKTX earnings date is April 30, 2020.

Analyst Predictions

3. What is VKTX stock forecast (i.e., prediction)?

Based on VKTX analyst price targets, VKTX stock forecast is $20.10 (for a year from now). That means the average analyst price target for VKTX stock is $20.10. The prediction is based on 3 analyst estimates.

The low price target for VKTX is $12.00, while the high price target is $40.00.

VKTX analyst rating is Buy.

Analysis

4. VKTX buy or sell? What is VKTX Finny Score?

#{finnyScore:67}Our quantitative analysis shows 4 reasons to buy and 2 reasons to sell VKTX, resulting in Finny Score of 67.

5. What are the reasons to buy VKTX? Why should I buy VKTX stock?

Here are the reasons to buy VKTX stock:

6. What are the reasons to sell VKTX? Why should I sell VKTX stock?

Let's look at the reasons to sell VKTX stock (i.e., the bear case):

  • VKTX short share of float is 22.17%. The stock is much more frequently shorted than the average industry, sector or S&P 500 stock. See VKTX short share of float chart.
  • VKTX short interest (days to cover the shorts) ratio is 8.03. The stock garners more short interest than the average industry, sector or S&P 500 stock. See VKTX short interest ratio chart.

Key Stats

7. What are VKTX key stats : revenue, market cap, revenue growth, profit margin, P/E ratio, P/B ratio industry, sector, and number of employees?

Let's look at the key statistics for VKTX:

Metrics VKTX
Price $7.67
Average Price Target / Upside $20.10 / 161.89%
Average Analyst Rating Buy
Forward Dividend Yield 0.00%
Industry Biotechnology
Sector Healthcare
Number of Employees 18
Market Cap $547.87M
Forward P/E Ratio -9.18
Price/Book Ratio N/A
Revenue (TTM) N/A
YoY Quarterly Revenue Growth N/A
Profit Margin 0.00%

If you liked this analysis, check out Stock Guides for other stocks.

Disclaimer: The news article above expresses the author’s opinion about the topic of the article. We strongly advise you not to base your investment decisions just on this article alone. If you’d like to become a writer for Finny Bites, please send us an email at hi@askfinny.com.

Use Finny to ask any finance or investment question. Big or small. Personal or general.
Follow Us